BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27692503)

  • 21. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type.
    Yong W
    Hematol Oncol; 2016 Jun; 34(2):61-8. PubMed ID: 25899032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
    Michot JM; Mazeron R; Danu A; Lazarovici J; Ghez D; Antosikova A; Willekens C; Chamseddine AN; Minard V; Dartigues P; Bosq J; Carde P; Koscielny S; De Botton S; Ferme C; Girinsky T; Ribrag V
    Eur J Cancer; 2015 Nov; 51(16):2386-95. PubMed ID: 26254810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal type natural killer T-cell lymphoma involving nasooropharynx and larynx.
    Köybaşı S; Seyhan S; Biçer YÖ; Üner A; Yeşilırmak A
    Kulak Burun Bogaz Ihtis Derg; 2014; 24(6):364-7. PubMed ID: 25547754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extranodal NK/T cell lymphoma, nasal type involving the larynx and digestive tract: a case report and literature review].
    Ma S; Chen X; Liu Z; Guo Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Nov; 37(11):920-923. PubMed ID: 37905488
    [No Abstract]   [Full Text] [Related]  

  • 27. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
    Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
    Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current management of nasal NK/T-cell lymphoma.
    Au WY
    Oncology (Williston Park); 2010 Apr; 24(4):352-8. PubMed ID: 20464847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
    Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
    Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of rare gastrointestinal lymphomas.
    Hawkes EA; Wotherspoon A; Cunningham D
    Leuk Lymphoma; 2012 Dec; 53(12):2341-50. PubMed ID: 22616672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
    Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
    Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extranodal NK/T-cell lymphoma, nasal type: a case report of 7-year natural course and review of literature.
    Du J; Ma PP; Wang QY; Chen CX; Li J
    Int J Clin Exp Pathol; 2015; 8(8):9620-8. PubMed ID: 26464728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric involvement of extranodal NK/T-cell lymphoma, nasal type: a report of 3 cases with literature review.
    Zhang YC; Sha Zhao ; Yu JB; Lei Shi ; He MX; Zhang HY; Liu WP
    Int J Surg Pathol; 2008 Oct; 16(4):450-4. PubMed ID: 18492683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal type NK/T-cell lymphoma - diagnosis and treatment difficulties.
    Hamidah NH; Shahrom S; Siti Aishah MA; Das S; Gendeh BS; Fadilah SA
    Clin Ter; 2014; 165(3):139-42. PubMed ID: 24999566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer/T-cell lymphoma, nasal type, masquerading as recalcitrant periodontitis in a patient with a diagnosis of Wegener's granulomatosis.
    Sokołowska-Wojdyło M; Florek A; Barańska-Rybak W; Sikorska M; Starzyńska A; Drogoszewska B; Włodarkiewicz A
    Am J Med Sci; 2013 Feb; 345(2):163-7. PubMed ID: 23111392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type, with a 22-year indolent clinical course.
    Zuriel D; Fink-Puches R; Cerroni L
    Am J Dermatopathol; 2012 Apr; 34(2):194-7. PubMed ID: 22172956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
    Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.